<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01836822</url>
  </required_header>
  <id_info>
    <org_study_id>IPU-DIMPA-WUM13(1)</org_study_id>
    <nct_id>NCT01836822</nct_id>
  </id_info>
  <brief_title>Bronchoscopic Sampling Techniques in Sarcoidosis</brief_title>
  <official_title>Diagnostic Accuracy of Different Bronchoscopic Sampling Techniques in Patients With Mediastinal Lymph Node Enlargement Suspected of Sarcoidosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The development of endobronchial ultrasound (EBUS) and EBUS-guided transbronchial needle
      aspiration (EBUS-TBNA) has improved the safety and diagnostic accuracy of the mediastinal
      lymph node (MLN) sampling. Still, in some diseases routine cytological specimens are
      considered insufficient and histological sampling is preferred. The aim of the study is to
      compare the diagnostic accuracy of EBUS-TBNA and two other, more invasive procedures to
      obtain histological samples from MLN in patients with clinical and radiological features of
      sarcoidosis.

      Bronchoscopy with bronchoalveolar lavage (BAL), EBUS-TBNA, EBUS guided transbronchial forceps
      biopsy (EBUS-TBFB), large bore (19G) histology TBNA as well as endobronchial forceps biopsy
      will be performed in 90 consecutive patients with mediastinal lymph node enlargement and
      clinical and radiological features of sarcoidosis.

      Diagnostic accuracy of each sampling technique will be calculated and compared to other
      techniques. Diagnostic yield of different technique combinations will also be calculated and
      the most efficient diagnostic approach will be defined.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of different bronchoscopic sampling methods in making the diagnosis of sarcoidosis.</measure>
    <time_frame>Approximately ten days after the procedure, when the results of the cytological and histopathological examination will be available</time_frame>
    <description>Comparison of the diagnostic yield of the cytologic and histologic specimens collected by EBUS-TBNA, EBUS-TBFB, large bore TBNA, endobronchial forceps biopsy and BAL in terms of making the diagnosis of sarcoidosis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adequacy of cytologic and histopathologic specimens collected by different sampling method as the diagnostic samples enabling confirmation of granulomatous lymph node disease.</measure>
    <time_frame>up to 9 months</time_frame>
    <description>Comparison of the number of patients in whom the specific sampling method has been undertaken (e.g. BAL, EBUS-TBNA, EBUS-TBFB and large bore TBNA) with the number of patients in whom the specific sampling method provided the adequate specimens, containing the elements of granulomas (also the relationship between the mediastinal lymph node dimension and the quality of the samples collected with different techniques)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Local complications of mediastinal lymph node sampling</measure>
    <time_frame>During and 24 hrs after bronchoscopic procedure</time_frame>
    <description>The number of patients in whom mediastinal vessels would be injured (resulting in endobronchial or extrabronchial bleeding). The number of patients with pneumothorax and/or pneumomediastinum complicating mediastinal sampling</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Mediastinal Lymph Node Enlargement</condition>
  <condition>Sarcoidosis</condition>
  <condition>Tuberculosis</condition>
  <condition>Lymphomas</condition>
  <arm_group>
    <arm_group_label>Bronchoscopic lymph node sampling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Several different sampling techniques will be used in each patient. They include: EBUS guided transbronchial needle aspiration (EBUS-TBNA), EBUS guided transbronchial forceps biopsy (EBUS-TBFB), large bore (19G) histologic needle biopsy of the mediastinal lymph nodes, forceps biopsy of bronchial mucosa in central and peripheral bronchi</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EBUS guided transbronchial forceps biopsy (EBUS-TBFB)</intervention_name>
    <arm_group_label>Bronchoscopic lymph node sampling</arm_group_label>
    <other_name>EBUS guided miniforceps biopsy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EBUS guided transbronchial needle aspiration (EBUS-TBNA)</intervention_name>
    <arm_group_label>Bronchoscopic lymph node sampling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>large bore (19G) histologic needle biopsy of the mediastinal lymph nodes</intervention_name>
    <arm_group_label>Bronchoscopic lymph node sampling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bronchoalveolar lavage (BAL)</intervention_name>
    <arm_group_label>Bronchoscopic lymph node sampling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endobronchial forceps biopsy</intervention_name>
    <arm_group_label>Bronchoscopic lymph node sampling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  provided informed consent

          -  mediastinal lymph node enlargement that requires bronchoscopy and transbronchial
             sampling

          -  clinical presentation that might be consistent with sarcoidosis

        Exclusion Criteria:

          -  age below 18 years

          -  known contraindications for bronchoscopy and/or mediastinal sampling, e.g. coagulation
             disorders

          -  lung or extrapulmonary tumors with suspicion of malignant mediastinal lymph node
             involvement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rafal Krenke, MD, PhD</last_name>
    <email>rafalkrenke@interia.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Piotr Korczynski, MD, PhD</last_name>
    <email>drkorczynski@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Internal Medicine, Pneumonology and Allergology, Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafal Krenke, MD, PhD</last_name>
      <phone>+48225992562</phone>
      <email>rafalkrenke@interia.pl</email>
    </contact>
    <contact_backup>
      <last_name>Piotr Korczynski, MD, PhD</last_name>
      <phone>+48225992562</phone>
      <email>drkorczynski@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Rafal Krenke, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Piotr Korczynski, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2013</study_first_submitted>
  <study_first_submitted_qc>April 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2013</study_first_posted>
  <last_update_submitted>February 11, 2014</last_update_submitted>
  <last_update_submitted_qc>February 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>Rafa≈Ç Krenke</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>mediastinal lymph node enlargement</keyword>
  <keyword>sarcoidosis</keyword>
  <keyword>bronchoscopy</keyword>
  <keyword>EBUS guided transbronchial needle aspiration (EBUS-TBNA)</keyword>
  <keyword>transbronchial needle aspiration (EBUS-TBNA)</keyword>
  <keyword>EBUS guided transbronchial forceps biopsy EBUS-TBFB)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Sarcoidosis</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Lymphadenopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

